Potentially immunogenic proteins expressed similarly in human embryonic stem cells and induced pluripotent stem cells

Experimental Biology and Medicine

Volumn 239, Issue 4, 2014, Pages 484-488

  Maynard, Kristen M ^a   Arvindam, Upasana ^a   Cross, Madeline ^a   Firpo, Meri T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Embryonic stem cells; immune rejection; induced pluripotent stem cells; transplant therapy; tumor antigens

Indexed keywords

EMBRYONIC STEM CELLS; IMMUNE REJECTION; INDUCED PLURIPOTENT STEM CELLS; TRANSPLANT THERAPY; TUMOR ANTIGENS;

CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOCHROME P-450 CYP3A; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LECTINS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84898946856     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214522936     Document Type: Article

References (21)

1. Zhao T,Zhang Z-N,Rong Z,Xu Y.Immunogenicity of induced pluripotent stem cells.Nature. 2011;474:212-15.
2. Araki R,Uda M,Hoki Y,Sunayama M,Nakamura M,Ando S,Sugiura M,Ideno H,Shimada A,Nifuji A,Abe M.Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.Nature. 2013;494:100-4.
3. Guha P,Morgan JW,Mostoslavsky G,Rodrigues NP,Boyd AS.Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.Cell Stem Cell. 2013;12:407-12.
4. Kim SA,Lee Y,Jung DE,Park KH,Park JY,Gang J,Jeon SB,Park EC,Kim YG,Lee B,Liu Q,Zeng W,Yeramilli S,Lee S,Koh SS,Song SY.Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma.Cancer Sci. 2009;100:828-36.
5. Lee Y,Kim SJ,Park HD,Park EH,Huang SM,Jeon SB,Kim JM,Lim DS,Koh SS.PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.Oncogene. 2010;29:56-67.
6. Park HD,Lee Y,Oh YK,Jung JG,Park YW,Myung K,Kim KH,Koh SS,Lim DS.Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation.Oncogene. 2011;30:201-11.
7. Cho IR,Koh SS,Malilas W,Srisuttee R,Moon J,Choi YW,Horio Y,Oh S,Chung YH.SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin.Biochem Biophys Res Commun. 2012;423:270-5.
8. Zhou YB,Cao JB,Yang HM,Zhu H,Xu ZG,Wang KS,Zhang X,Wang ZQ,Han ZG.hZG16, a novel human secreted protein expressed in liver, was down-regulated in hepatocellular carcinoma.Biochem Biophys Res Commun. 2007;355:679-86.
9. Chen Y-T,Venditti CA,Theiler G,Stevenson BJ,Iseli C,Gure AO,Jongeneel CV,Old LJ,Simpson AJ.Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein.Cancer Immunity. 2005;5:9-9.
10. Adélaïde J,Finetti P,Bekhouche I,Repellini L,Geneix J,Sircoulomb F,Charafe-Jauffret E,Cervera N,Desplans J,Parzy D,Schoenmakers E,Viens P,Jacquemier J,Birnbaum D,Bertucci F,Chaffanet M.Integrated profiling of basal and luminal breast cancers.Cancer Res. 2007;67:11565-75.
11. Shahzad MM,Shin YH,Matsuo K,Lu C,Nishimura M,Shen DY,Kang Y,Hu W,Mora EM,Rodriguez-Aguayo C,Kapur A,Bottsford-Miller J,Lopez-Berestein G,Rajkovic A,Sood AK.Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.Cancer Lett. 2013;330:123-9.
12. Perera MA.The missing linkage: what pharmacogenetic associations are left to find in CYP3A?.Expert Opin Drug Metab Toxicol. 2010;6:17-28.
13. Johnson N,Walker K,Gibson LJ,Orr N,Folkerd E,Haynes B,Palles C,Coupland B,Schoemaker M,Jones M,Broderick P,Sawyer E,Kerin M,Tomlinson IP,Zvelebil M,Chilcott-Burns S,Tomczyk K,Simpson G,Williamson J,Hillier SG,Ross G,Houlston RS,Swerdlow A,Ashworth A,Dowsett M,Peto J,Dos Santos Silva I,Fletcher O.CYP3A variation, premenopausal estrone levels, and breast cancer risk.J Natl Cancer Inst. 2012;104:657-69.
14. Zhou LP,Yao F,Luan H,Wang YL,Dong XH,Zhou WW,Wang QH.CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.Tumour Biol. 2013;34:649-60.
15. Fujimura T,Takahashi S,Urano T,Tanaka T,Zhang W,Azuma K,Takayama K,Obinata D,Murata T,Horie-Inoue K,Kodama T,Ouchi Y,Homma Y,Inoue S.Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer.Cancer Sci. 2012;103:176-80.
16. Enosawa S,Yamazaki T,Kohsaka H,Tokiwa T.Repopulation of human origin hepatocyte progenitor-like cell line, THLE-5b, in the SCID mouse liver under p21-mediated cell growth-arresting conditions.Cell Transplantation. 2012;21:447-52.
17. Fukumitsu K,Ishii T,Yasuchika K,Amagai Y,Kawamura-Saito M,Kawamoto T,Kawase E,Suemori H,Nakatsuji N,Ikai I,Uemoto S.Establishment of a cell line derived from a mouse fetal liver that has the characteristic to promote the hepatic maturation of mouse embryonic stem cells by a coculture method.Tissue Eng Part A. 2009;15:3847-56.
18. Nichols J,Smith A.Naïve and primed pluripotent states.Cell Stem Cell. 2009;4:487-92.
19. Hanna JH,Saha K,Jaenisch R.Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.Cell. 2010;143:508-25.
20. Hirai H,Firpo M,Kikyo N.Establishment of LIF-dependent human iPS cells closely related to basic FGF-dependent authentic iPS cells.PLoS One. 2012;7:e39022-e39022.
21. Boyd AS,Rodrigues NP,Lui KO,Fu X,Xu Y.Concise review: immune recognition of induced pluripotent stem cells.Stem Cells. 2012;30:797-80.